Restoring FAS expression by reversing FAS promoter methylation: A novel approach to CTCL therapy

被引：0
|
作者：
Wu, J. [1 ,2 ]
Wood, G. S. [1 ,2 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] VAMC, Madison, WI USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2010年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
173
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [21] Modulation of Fas expression: A potential therapy for cholangiocarcinoma.
    Jhala, N
    Pan, G
    Ahn, EY
    Vickers, SM
    McDonald, JM
    LABORATORY INVESTIGATION, 2001, 81 (01) : 197A - 197A
  • [22] Reduction of Fas/CD95 Promoter Methylation, Upregulation of Fas Protein, and Enhancement of Sensitivity to Apoptosis in Cutaneous T-Cell Lymphoma
    Wu, Jianqiang
    Wood, Gary S.
    ARCHIVES OF DERMATOLOGY, 2011, 147 (04) : 443 - 449
  • [23] Modulation of Fas expression: A potential therapy for cholangiocarcinoma.
    Jhala, N
    Pan, G
    Ahn, EY
    Vickers, SM
    McDonald, JM
    MODERN PATHOLOGY, 2001, 14 (01) : 197A - 197A
  • [24] A CD95 promoter polymorphism alters quantitative Fas expression.
    Mangan, EK
    Wu, J
    Edberg, JC
    Kimberly, RP
    FASEB JOURNAL, 2000, 14 (06): : A1208 - A1208
  • [25] Early apoptosis and FAS expression for therapy monitoring in HIV infection
    Aries, SP
    Schaaf, B
    Weyrich, K
    Braun, J
    Dennin, RH
    Dalhoff, K
    AIDS, 1996, 10 : P68 - P68
  • [26] Manipulating and monitoring Fas expression by cutaneous T-cell lymphoma (CTCL) tumor cells in vitro and in vivo
    Wu, J.
    Stutz, N.
    Wood, G. S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S21 - S21
  • [27] miR-20a Regulates FAS Expression in Osteosarcoma Cells by Modulating FAS Promoter Activity and Can be Therapeutically Targeted to Inhibit Lung Metastases
    Yang, Yuanzheng
    Huang, Gangxiong
    Zhou, Zhichao
    Fewell, Jason G.
    Kleinerman, Eugenie S.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01) : 130 - 139
  • [28] Promoter methylation of fas apoptotic inhibitory molecule 2 gene is associated with obesity and dyslipidaemia in Chinese children
    Wu, Lijun
    Zhao, Xiaoyuan
    Shen, Yue
    Zhang, Mei-Xian
    Yan, Yinkun
    Hou, Dongqing
    Meng, Linghui
    Liu, Junting
    Cheng, Hong
    Mi, Jie
    DIABETES & VASCULAR DISEASE RESEARCH, 2015, 12 (03): : 217 - 220
  • [29] FAS ANTIGEN EXPRESSION IN LIVER-TISSUES DURING INTERFERON THERAPY
    MOCHIZUKI, K
    HAYASHI, N
    HIRAMATSU, N
    KATAYAMA, K
    KAWANISHI, Y
    KASAHARA, A
    FUSAMOTO, H
    KAMADA, T
    HEPATOLOGY, 1994, 20 (04) : A164 - A164
  • [30] Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death - Implications for vascular disease and therapy
    Sata, M
    Suhara, T
    Walsh, K
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (02) : 309 - 316
12345